The persistence of pain after surgery increases the recovery interval from surgery to a normal quality of life. AYX1 is a DNA-decoy drug candidate designed to prevent post-surgical pain following a single intrathecal injection. Tissue injury causes a transient activation of the transcription factor EGR1 in the dorsal root ganglia-dorsal horn network, which then triggers changes in gene expression that induce neuronal hypersensitivity. AYX1 is a potent, specific inhibitor of EGR1 activity that mimics the genomic EGR1-binding sequence. Administered in the peri-operative period, AYX1 dose dependently prevents mechanical hypersensitivity in models of acute incisional (plantar), inflammatory (CFA), and chronic neuropathic pain (SNI) in rats. Furthermore, in a knee surgery model evaluating functional measures of postoperative pain, AYX1 improved weight-bearing incapacitance and spontaneous rearing compared to control. These data illustrate the potential clinical therapeutic benefits of AYX1 for preventing the transition of acute to chronic post-surgical pain.
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The persistence of pain after surgery increases the recovery interval from surgery to a normal quality of life. AYX1 is a DNA-decoy drug candidate designed to prevent post-surgical pain following a single intrathecal injection. Tissue injury causes a transient activation of the transcription factor EGR1 in the dorsal root ganglia-dorsal horn network, which then triggers changes in gene expression that induce neuronal hypersensitivity. AYX1 is a potent, specific inhibitor of EGR1 activity that mimics the genomic EGR1-binding sequence. Administered in the peri-operative period, AYX1 dose dependently prevents mechanical hypersensitivity in models of acute incisional (plantar), inflammatory (CFA), and chronic neuropathic pain (SNI) in rats. Furthermore, in a knee surgery model evaluating functional measures of postoperative pain, AYX1 improved weight-bearing incapacitance and spontaneous rearing compared to control. These data illustrate the potential clinical therapeutic benefits of AYX1 for preventing the transition of acute to chronic post-surgical pain.
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Introduction
With 30 million surgical procedures performed annually in the United States, post-surgical pain constitutes a public health issue [11] . Its most debilitating component is the mechanical hypersensitivity associated with movement-evoked pain, which is poorly treated by current therapeutics [34, 35] . Consequently, $80% of patients suffer moderate to severe acute perioperative pain for weeks after hospital discharge, and approximately 10% to 50% develop chronic pain [2,17,19,23]. Mechanical hypersensitivity after surgery results from a pathophysiological gain in excitability of the dorsal root ganglia (DRG) and dorsal horn neuronal network. It is a dynamic phenomenon initiated within minutes after injury, with the launch of multi-phasic, genome-wide waves of gene regulation driving long-term neuronal hypersensitivity through a variety of cellular mechanisms. These gene-regulatory events follow a temporal hierarchy: an immediate-early transcriptional phase is first induced after injury, and triggers delayed transcription waves responsible for sustained neuronal sensitization [9, 15, 22, 30, 36] .
Early growth response 1 (EGR1) is a transcription factor essential for the early transcriptional response to a noxious injury: its immediate activation after injury triggers delayed, long-term transcriptional and neuronal excitability changes necessary to the development of pain and mechanical hypersensitivity. EGR1 is transiently induced in DRG and dorsal horn neurons in response to surgical incision and a wide range of other painful injuries, including thermal, biochemical/chemical, ischemic, inflammatory, and neuropathic [3, 13, 14, 21, 30] . Microarray studies established that EGR1 target genes encompass most of the molecular players involved in pain control, including immune response, translation, apoptosis,
